Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Jukema

Showing results (131-140 of 202) with videos related to

Pageof 21
Sort By:
Circulation|April 3, 2001
Acyl-CoA:cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE*3-Leiden miceD J Delsing, E H Offerman, W van Duyvenvoorde, et al.
Heart (British Cardiac Society)|March 28, 2014
The dialysis procedure as a trigger for atrial fibrillation: new insights in the development of atrial fibrillation in dialysis patientsM S Buiten, M K de Bie, J I Rotmans, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 28, 2005
No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-leiden/human C-reactive protein transgenic miceA Trion, M P M de Maat, J W Jukema, et al.
International Journal of Cardiology|June 27, 2020
Blood transfusion and ischaemic outcomes according to anemia and bleeding in patients with non-ST-segment elevation acute coronary syndromes: Insights from the TAO randomized clinical trialP Deharo, G Ducrocq, C Bode, et al.
Circulation|October 4, 2000
Lipoprotein lipase activity is associated with severity of angina pectoris. REGRESS Study GroupJ J Kastelein, J W Jukema, A H Zwinderman, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 13, 2001
Raman spectroscopic evaluation of the effects of diet and lipid-lowering therapy on atherosclerotic plaque development in miceS W van De Poll, T J Römer, O L Volger, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|January 15, 2016
Treatment variation in stent choice in patients with stable or unstable coronary artery diseaseL T Burgers, E A McClellan, I E Hoefer, et al.
The International Journal of Cardiovascular Imaging|May 27, 2011
Performance and efficacy of 320-row computed tomography coronary angiography in patients presenting with acute chest pain: results from a clinical registryJ E van Velzen, F R de Graaf, L J Kroft, et al.
Research and Practice in Thrombosis and Haemostasis|July 2, 2024
Performance of risk scores in predicting major bleeding in left ventricular assist device recipients: a comparative external validationS F B van der Horst, Y de Jong, N van Rein, et al.
Clinical Genetics|April 29, 1998
The Asn9 variant of lipoprotein lipase is associated with the -93G promoter mutation and an increased risk of coronary artery disease. The Regress Study GroupJ J Kastelein, B E Groenemeyer, D M Hallman, et al.
Pageof 21

Showing results (131-140 of 202) with videos related to

Sort By:
Pageof 21
Circulation|April 3, 2001
Acyl-CoA:cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE*3-Leiden miceD J Delsing, E H Offerman, W van Duyvenvoorde, et al.
Heart (British Cardiac Society)|March 28, 2014
The dialysis procedure as a trigger for atrial fibrillation: new insights in the development of atrial fibrillation in dialysis patientsM S Buiten, M K de Bie, J I Rotmans, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 28, 2005
No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-leiden/human C-reactive protein transgenic miceA Trion, M P M de Maat, J W Jukema, et al.
International Journal of Cardiology|June 27, 2020
Blood transfusion and ischaemic outcomes according to anemia and bleeding in patients with non-ST-segment elevation acute coronary syndromes: Insights from the TAO randomized clinical trialP Deharo, G Ducrocq, C Bode, et al.
Circulation|October 4, 2000
Lipoprotein lipase activity is associated with severity of angina pectoris. REGRESS Study GroupJ J Kastelein, J W Jukema, A H Zwinderman, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 13, 2001
Raman spectroscopic evaluation of the effects of diet and lipid-lowering therapy on atherosclerotic plaque development in miceS W van De Poll, T J Römer, O L Volger, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|January 15, 2016
Treatment variation in stent choice in patients with stable or unstable coronary artery diseaseL T Burgers, E A McClellan, I E Hoefer, et al.
The International Journal of Cardiovascular Imaging|May 27, 2011
Performance and efficacy of 320-row computed tomography coronary angiography in patients presenting with acute chest pain: results from a clinical registryJ E van Velzen, F R de Graaf, L J Kroft, et al.
Research and Practice in Thrombosis and Haemostasis|July 2, 2024
Performance of risk scores in predicting major bleeding in left ventricular assist device recipients: a comparative external validationS F B van der Horst, Y de Jong, N van Rein, et al.
Clinical Genetics|April 29, 1998
The Asn9 variant of lipoprotein lipase is associated with the -93G promoter mutation and an increased risk of coronary artery disease. The Regress Study GroupJ J Kastelein, B E Groenemeyer, D M Hallman, et al.
Pageof 21